The M current (I K(M) ) is a low-threshold, slowly activating potassium current that exerts an inhibitory control over neuronal excitability; this inhibition can be relieved by neurotransmitters acting on G-protein-coupled receptors, leading to enhanced excitability and reduced spike-frequency adaptation (Brown, 1988; Marrion, 1997) . The current was originally described in sympathetic neurons (Brown and Adams, 1980; Constanti and Brown, 1981) , and analogous currents have subsequently been identified in a variety of other neuronal and non-neuronal cells. Because the precise kinetic and pharmacological properties of the current vary somewhat in different cell types, the name "M-like" is often applied to this current family.
Recently, evidence has been provided to indicate that the channels that generate the M current in rat sympathetic neurons are composed of a heteromeric assembly of KCNQ2 and KCNQ3 subunits (Wang et al., 1998 ; see also Yang et al., 1998) . These are two homologs of the KCNQ1 (KvLQT1) channel, mutations of which are responsible for one form of the cardiac "long QT" syndrome (Yang et al., 1997) . In contrast, KCNQ2 and KCNQ3 are restricted to the nervous system, and mutations in these channels are associated with a form of infant epilepsy termed "benign familial neonatal convulsions" (Biervert et al., 1998; Charlier et al., 1998; Schroeder et al., 1998; Singh et al., 1998) . However, it is not yet known whether all M-like channels are composed of these two subunits (or homologs thereof), or whether members of other K ϩ channel gene families might contribute to the generation of M-like currents.
In the present experiments, we have attempted to identify the molecular species of K ϩ channels that generate the M-like current (I K(M,ng) ) in NG108 -15 mouse neuroblastoma x rat glioma cells. These currents have been particularly well characterized (Higashida and Brown, 1986; Brown and Higashida, 1988a,b; Fukuda et al., 1988; Schafer et al., 1991; Robbins et al., 1992 Robbins et al., , 1993 Selyanko et al., 1995) . Like the channels in sympathetic neurons, they are inhibited by transmitters acting on G-proteinlinked receptors coupled to phospholipase C (e.g., bradykinin and M 1 and M 3 muscarinic receptors) (Higashida and Brown, 1986; Fukuda et al., 1988) , with similar consequences for cell firing (Robbins et al., 1993) . On the other hand, the kinetics of I K(M,ng) appear more complex than those of the ganglionic M current (Robbins et al., 1992) , and the two currents differ in their sensitivities to 9-aminotetrahydroacridine (cf. Marsh et al., 1990; Robbins et al., 1992) and linopirdine (cf. Aiken et al., 1995; Lamas et al., 1997; Noda et al., 1998) . It has previously been suggested that Shaker-type Kv1.2 channels, cloned from NG108 -15 cells (Yokoyama et al., 1989) , may contribute to I K(M,ng) (Morielli and Peralta, 1995) . However, the insensitivity of I K(M,ng) to dendrotoxin (Selyanko et al., 1995) makes this unlikely. Instead, we provide evidence to indicate that two different types of K ϩ channel contribute to the M-like current in NG108 -15 cells: the mouse ether-a-go-go-related gene (merg1a), also expressed in the brain (London et al., 1997) , and KCNQ2/KCNQ3, the proposed substrate for the ganglionic current (Wang et al., 1998) .
MATERIALS AND METHODS
Cell cultures. NG108 -15 mouse neuroblastoma x rat glioma hybrid cells, subclone BM8 (PM1), transfected to express pig brain M 1 muscarinic receptor (Fukuda et al., 1988) , were cultured and differentiated as described previously (Robbins et al., 1992) . Chinese hamster ovary (CHO) cells stably transfected with cDNA encoding human M 1 muscarinic Figure 1 . Pharmacological separation of two components of the M-like (I K(M,ng) ) current in NG108 -15 mouse neuroblastoma x rat glioma cells. M-like currents recorded in two cells (A, B) as deactivating tail currents produced by voltage steps from Ϫ20 mV (holding potential) to Ϫ50 mV. In each cell, the control current had two different components, fast and slow, which could be blocked by WAY 123,398 and linopirdine, respectively. Insets on the right show the difference (blocker-sensitive) currents. The current in A consisted predominantly of the slow component (blocked by WAY 123,398), whereas that in B was predominantly fast and blocked by linopirdine. receptors were maintained in culture as described in Mullaney et al. (1993) . Superior cervical ganglion neurons were prepared as described previously (Owen et al., 1990 ) from 6-week-old C57 mice and 14-d-old Sprague Dawley rats, and used after 1-2 d in culture. Recordings from all three types of cell were made at room temperature (20 -22°C), under identical experimental conditions (solutions, pipettes, etc.) . Culture and transfection of CHO hm1 cells. CHO hm1 cells are CHO-K1 cells, previously transfected with the human M 1 receptor (Mullaney et al., 1993) . C ells were grown in 50 ml flasks at 37°C and 5% C O 2 . The culture medium was ␣-M EM supplemented with 10% fetal calf serum, 1% L-glutamine, and 1% penicillin /streptomycin. C ells were split twice weekly when confluent, plated in 35 mm dishes, and transfected 1-2 d after plating using "LipofectAmine Plus" (Life Technologies, Gaithersburg, MD) according to the manufacturer's recommendations. Plasmids containing merg1a and CD8 cDNAs, both driven by cytomegalovirus promoter, were cotransfected in a ratio of 10:1. C ells for patch clamping were identified by adding CD8-binding Dynabeads (Dynal, Great Neck, N Y) the day after transfection. For immunocytochemistry, a plasmid containing cDNA for jellyfish green fluorescent protein (GFP) was used as a marker for transfection.
Reverse transcription PCR . RNA was extracted from cell lines and superior cervical ganglia (SCG) using RNAzol B (Biogenesis L td.) and reverse-transcribed using oligo-dT and mouse murine leukemia virus reverse transcriptase (Promega, Madison, W I). The oligonucleotides used to amplif y the erg gene family were: erg-s 5Ј CCC YTTCAAGGC -MGTGTGGG and erg-a 5Ј C TGGTHAGRC TGC TGAAGGT. Primers were designed such that the amplified product spanned at least one intron to ensure amplification products were not derived from contaminating genomic DNA. The primers used for KCNQ PCR were KCNQs 5ЈACCT-GGARGC TBC TGGC TC and KCNQa 5ЈCCKC TYTTCTCAAAGT-GCTTCTG. These primers were designed to amplif y both KCNQ2 and KCNQ3 sequences. C ycling conditions were 95°C for 5 min and then 30 cycles of 95°C for 30 sec; 60°C for 1 min and 72°C for 1 min followed by a final step of 72°C for 10 min. Aliquots of the reaction mixture were visualized on a 2% (w/ v) Metaphor agarose (FMC BioProducts, Rockland, M E). PCR products were cloned using the pGEM-T vector (Promega) and recombinant plasmids sequenced using Taq polymerase, fluoresceinated dye terminators and an Applied Biosystems 377 automated DNA sequencer.
Immunoc ytochemistr y. This was performed using antibodies raised against synthetic peptides corresponding to the last 14 amino acids of the C -terminal fragment of merg1 (merg1-C T) and the first 17 amino acids of merg1b (merg1-N T), respectively. NG108 -15 cells were seeded onto polyornithine-coated glass coverslips to allow immunocytochemistry. NG108 -15 cells were washed in TBS (5.5 mM Tris, pH 7.4, and 137 mM NaC l) and fixed in acetone for 20 min at room temperature. The fixed cells were then treated with normal swine serum (1:10) in TBS for 30 min. Once excess serum was removed, the merg1-C T primary antibody was applied at 1:1000 dilution for 1 hr at room temperature. Different concentrations of the primary antibody were tested to optimize immunochemical labeling and minimize nonspecific staining of the tissue background. Bound antibodies were then detected using alkaline phosphatase-conjugated secondary antibodies (1:500; Dako, C arpinteria, CA), largely as described in Abogadie et al. (1997) . Transfected mammalian CHO cells were briefly washed with PBS and fixed for 20 -30 min in PBS containing 4% paraformaldehyde. Fixed cells were then rinsed Figure 2 . Kinetic analysis of the M-like current in a NG108 -15 mouse neuroblastoma x rat glioma cell. Total I K(M,ng) was activated by holding at Ϫ20 mV and then deactivated by a 6 sec step (top record) to Ϫ50 mV before ( A) and after ( B) addition of the erg-channel blocker WAY 123,398 (10 M). In control ( A) the deactivation tail was fitted (smooth line, superimposed) by the sum of fast ( ϭ 76 msec, 254 pA) and two slow ( ϭ 340 msec, 37 pA and 2124 msec, 70 pA) exponential curves. WAY 123,398 abolished both slow components without affecting the fast component (B, ϭ 76 msec). C, Slow component obtained by subtracting the record shown in B from that shown in A was fitted (smooth line, superimposed) by the sum of two kinetic components ( ϭ 315 and 1972 msec). All records were obtained from the same cell. Dashed lines denote zero current levels. Figure 3 . cDNA from mouse SCG, rat SCG, and chemically differentiated NG108 -15 cells, was amplified using primers to the erg family of potassium channel genes or primers recognizing KCNQ2 and KCNQ3 potassium channel genes. Amplified products were obtained from all cell types but not from a negative control containing no template, indicating that members of these families are expressed by these cells. Sequence analysis revealed that the amplified product obtained from NG108 -15 cDNA with primers to the erg genes was predominantly, if not exclusively, merg1. Analysis of the amplified product obtained using the KCNQ primers in both rat SCG and NG108 -15 has shown these cells express both KCNQ2 and KCNQ3. M-1 kb ladder DNA size standards.
with PBS, blocked for 10 min with BSA, and permeabilized with 0.1% Triton X-100 for 5 min. Incubation with the anti-merg1 antibody and labeling were carried out as described for the NG108 -15 cells.
Perforated-patch whole-cell recording. C ells were bath-perf used with the solution of the following composition (in mM): 144 NaC l, 2.5 KC l, 2 CaCl 2 , 0.5 MgC l 2 , 5 H EPES, and 10 glucose, pH 7.4, with Tris base. Pipettes were filled with the "internal" solution containing 90 mM K acetate, 20 mM KC l, 40 H EPES, 3 MgC l 2 , 3 mM EGTA, and 1 mM CaCl 2 . The pH was adjusted to 7.4 with NaOH. Amphotericin B was used to perforate the patch (Rae et al., 1991) . The series resistance was not compensated because the error introduced was reasonably small. Thus, with the electrodes used (2-3 M⍀), the series resistance was 6 -8 M⍀, and most of the currents were Ͻ0.5 nA, so the voltage error would be Ͻ5 mV. As confirmation that the voltage error was small, no correlation was found between deactivation time constants and initial current amplitude.
Data acquisition and anal ysis. Data were acquired and analyzed using pC lamp software (version 6.0.3). Currents were recorded using an Axopatch 200A (or 200) patch-clamp amplifier, filtered at 1 kHz, and digitized at 1-4 kHz. In current-clamp experiments, currents were injected, and membrane potential was recorded using an Axoclamp-2 amplifier. Activation curves were fitted by the Boltzmann equation:
, where I is current at the test potential (estimated from the amplitudes of exponentials backfitted to the beginning of the test step), I(50) is current at ϩ50 mV, V 1/2 is the membrane potential, V, at which I is equal to 1 ⁄2 I(50). Inhibition of the current was measured from the change in the amplitude of the deactivation tail recorded at Ϫ50 mV. Each tail was fitted by one or more exponentials, and the tail amplitude was taken as the sum of the amplitudes of all components contributing to it after backfitting them to the beginning of the hyperpolarizing pulse. In cells that had the erg-type component, backfitting was necessary to exclude not only the (relatively fast) capacity transient, but also the brief rising phase of the tail caused by the deinactivation of erg-type channels. To include the fast component (when present) in the fit, we had to position the fitting cursor earlier in the trace than was appropriate for the pure erg current. This tends to skew the values obtained for the erg components to larger values. This may explain the difference in slow values between the total and WAY 123,398-sensitive currents (Table 1) . Inhibition curves were fitted by the Hill equation: Y ϭ Y max * x nH /(x nH ϩ IC 50 nH ), where Y max is the maximum inhibition, x is the blocker concentration, n H is the slope (Hill coefficient), and IC 50 is the concentration corresponding to the half-maximal inhibition. Individual currents were measured and fitted using the C lampfit software, whereas the program "Origin" (version 5.0, Microcal Software) was used for fitting activation and inhibition curves and for creating the figures.
Drugs and chemicals. Linopirdine (DuP 996) was obtained from Research Biochemicals (Natick, M A). WAY 123,398 and azimilide were kindly provided by Wyeth-Ayerst Research (Princeton, NJ) and Dr. A. Busch (DG C ardiovascular, Frankf urt, Germany), respectively. All other drugs and chemicals were obtained from Sigma or BDH Chemicals (Poole, UK).
RESULTS

Fast and slow M-like (I K(M,ng) ) currents in NG108-15 mouse neuroblastoma x rat glioma cells
We recorded M-like currents (I K(M,ng) ) from 101 chemically differentiated NG108 -15 cells using perforated-patch electrodes. Cells were caref ully selected for their "neuron-like" appearance, i.e., large size and well-developed neuropil (Robbins et al., 1992) . When studied with the conventional M-current voltage protocol, that is, by stepped hyperpolarization after predepolarization to approximately Ϫ20 mV (see Materials and Methods), currents showed characteristic M-like deactivation tails. However, the time course of these tail currents varied considerably from one cell to another. Figure 1 illustrates two extreme examples of this variation. Thus, in Figure 1 A, deactivation during a 6 sec hyperpolarizing step was very slow, with an apparent "time-constant" of ϳ2 sec, whereas in Figure 1 B, deactivation was complete within 2 sec.
Because a number of tumor cells (including neuroblastoma cells) have been reported to express HERG-like currents with relatively slow rates of deactivation (Bianchi et al., 1998) , we wondered whether these might contribute to the long deactivation tails. We tested this pharmacologically, using the HERG channelblocking drug WAY 123,398 (Spinelli et al., 1993; Faravelli et al., 1996) . As shown in Figure 1 A, 10 M WAY 123,398 blocked most of the long deactivation, leaving a residual fast component which was then eliminated by the M channel-blocking drug linopirdine (Aiken et al., 1995; Lamas et al., 1997) . In contrast, the fastdeactivating current in Figure 1 B was strongly blocked by linopirdine, leaving a slower component that was blocked in turn by WAY 123,398. Thus, comparison of the linopirdine-and WAYsensitive currents (Fig. 1, inserts) showed that in fact each cell had two components to the deactivation currents, fast and slow, and that the overall time course of current deactivation was determined by their proportion. Furthermore, both components contributed to the sustained current recorded at Ϫ20 mV.
Because 10 M WAY 123,398 produces a complete block of erg channels without affecting other K ϩ channels such as sympathetic neuron M channels (see below), we analyzed the fast and slow components of the deactivation tails in more detail by recording currents in the absence and presence of WAY 123,398. Figure 2 exemplifies the results obtained in 86 of 101 cells so examined. Here, the control current recorded in the absence of WAY 123,398 (Fig. 2 A) showed three components, a fast component with a time constant of 76 msec, and a slower, biexponential component with time constants of 340 msec and 2.1 sec. WAY 123,398 (Fig. 2 B) eliminated the slower component, leaving only the fast component (, 75 msec), whereas the difference (WAYsensitive) current (Fig. 2C) showed only the biexponential slow component (, 315 msec and 2.0 sec). Thus, the time constants of the residual current recorded after application of WAY 123,398 and of the subtracted (WAY-sensitive) current accurately repro- Figure 5 . Characteristics of the merg1a current (I merg1a ) expressed in CHO cells. I merg1a was activated by long (8 sec) depolarizing voltage steps from the holding level of Ϫ80 mV (Aa) and deactivated by hyperpolarizing steps after its f ull activation by a prepulse to ϩ50 mV (Ba). Leaksubtracted steady-state I-V relationships obtained at the end of the depolarizing and hyperpolarizing pulses, respectively, are shown in Ab and Bb (open circles), and an "instantaneous" I-V relationship obtained at the beginning of the hyperpolarizing pulses for current deactivation is shown in Bb ( filled circles). Activation (Ac) and deactivation (Bc) time constants were plotted semilogarithmically, and -V relationships were fitted by straight lines with at 0 mV and the slope equal to 1218 Ϯ 1 msec and Ϫ0.013 Ϯ 0.001 mV Ϫ1 in Ac and 403 Ϯ 1 msec and 0.012 Ϯ 0.0006 mV Ϫ1 ( filled circles) and 3437 Ϯ 1 msec and 0.014 Ϯ 0.002 mV Ϫ1 (open circles) in Bc. C, Activation curve fitted by the Boltzmann equation at V 1/2 ϭ Ϫ5.9 Ϯ 0.6 mV and k ϭ 12.2 Ϯ 0.5 mV. Records in Aa and Ba were from the same cell. In Ab, Ac, Bb, Bc, and C the mean data are shown (vertical lines indicate SEMs) obtained from six and nine cells, respectively. duced the fast and slow components of the composite initial current. In this cell, the fast and slow components contributed 70 and 30%, respectively of the total tail current, and both contributed to the steady outward current at the holding potential as judged from the effect of WAY 123,398 on the holding current. On average, in the 86 cells expressing both currents, the fast-and slow-deactivating components contributed ϳ33 and 67%, respectively, to the total tail current (Table 1 ). In the other 15 cells, the tail current showed only the slowly deactivating component and was fully suppressed by WAY 123,398.
mRNAs for merg1 and KCNQ2 and KCNQ3 in NG108-15 cells
The clearly distinguishable effects of linopirdine and WAY 123,398 on the tail currents illustrated in Figures 1 and 2 suggested that these might be composite currents, resulting from the deactivation of two different species of K ϩ channel: one composed of linopirdine-sensitive KCNQ2/3 subunits, or homologs thereof (Wang et al., 1998) , and the other comprising a member (or members) of the erg family. We therefore sought evidence for the presence of transcripts of these channels by RT-PCR (see Materials and Methods). Transcripts for both erg and KCNQ2/3 were detected (Fig. 3) .
Sequence analysis of 10 independent clones from the erg PCR showed that each clone contained erg1 DNA sequence (data not shown), suggesting that these cells express predominantly, if not exclusively, merg1 transcript (London et al., 1997) . The KCNQ2/3 transcript contained mRNA for both KCNQ2 and KCNQ3. It may be noted in Fig. 3 that these transcripts were also present in dissociated neurons from mouse and rat SCG (see also Shi et al., 1997; Wang et al., 1998) .
Merg1 protein expression in chemically differentiated NG108-15 cells
The presence of mRNA transcripts does not necessarily correlate with translated protein products. We therefore tested for the expression of merg1a protein in NG108 cells by immunocytochemistry using a specific antibody raised against the C-terminal fragment of merg1 (merg1-C T; see Materials and Methods). As a control for specificity, the merg1-C T primary antibody was preincubated overnight with a 10-fold molar excess of the immunogenic peptide. Figure 4 , A and B, compare merg1 immunolabeling in chemically differentiated and nondifferentiated NG108 -15 cells, respectively. Strong labeling was observed in both cell bodies and neuropil of most large chemically differentiated NG108 -15 cells of the type we normally selected for electrophysiological recording, whereas smaller cells with less well-developed processes showed weak or no immunoreactivity. No staining was observed in cells treated with preabsorbed antibody. Nondifferentiated cells, which normally expressed very small I K(M,ng) , showed moderate or no staining. Interestingly, no staining was observed in dissociated mouse SCG neurons (Fig. 4C) , or over the underlying glial cell layer. This latter (negative) finding accords with the absence of any effect of WAY 123,398 on membrane currents recorded from these neurons (see below). Also, no immunostaining of differentiated NG108 -15 cells was detected after exposure to an antibody raised against an N-terminal sequence unique to the short form of merg1 (merg1b), the expression of which is restricted to cardiac cells (London et al., 1997) . This suggests that the protein tagged by the C-terminal antibody is the product of the long-form transcript merg1a (London et al., 1997; see also below).
Strong immunoreactivity for merg1-CT antibody was also detected in CHO cells transfected with merg1a cDNA. No staining was observed in untransfected cells, in cells transfected only with the GFP plasmid, or in cells treated with preabsorbed antibody (data not shown).
Slow I K(M,ng) is mimicked by merg1a current (I merg1a ) expressed in CHO cells
The above results suggested that the slow component of the M-like current in NG108 -15 cells might well be carried by merg1a channels. We tested this further by expressing merg1a cDNA in mammalian CHO cells. Figure 5 illustrates the resultant membrane currents. I merg1a was activated by membrane depolarization to equal or positive to Ϫ40 mV, but showed substantial inactivation during the (long) depolarizing command at potentials positive to 0 mV (Fig. 5Aa) . As a result, the "steady-state" current-voltage curve was "bell-shaped" (Fig. 5Ab) . The time course of this composite activation (accompanied by inactivation) could be described by two exponentials, accelerating strongly with depolarization (Fig. 5Ac) . When the cell was hyperpolarized after a depolarizing prepulse to ϩ50 mV, there was a large transient enhancement of the current, caused by removal of channel inactivation, followed by a slower deactivation (Fig.  5Ba,b) . Two deactivation components were detected that were strongly shortened by membrane hyperpolarization (Fig. 5Bc) . The mean activation curve deduced from tail currents followed a Boltzmann equation with V 1/2 ϭ Ϫ5.9 Ϯ 0.6 mV and k ϭ 12.2 Ϯ 0.5 mV (Fig. 5C ). However, when individual curves were fitted, they showed a great variation in V 1/2 (range, between Ϫ27 and 13 mV; n ϭ 9) and small variation in k (range, between 6.9 and 10). These results accord well with previous observations on merg1a currents in oocytes (London et al., 1997) .
We next compared the properties of I merg1a deactivation more closely with those of the WAY-sensitive slow component of I K -(M,ng), using the "standard" M current protocol, that is, currents were preactivated by holding at the depolarized potential of 0 mV (Ϫ20 mV in the case of I K(M,ng) , to avoid contamination by other, primarily Ca 2ϩ -dependent, K ϩ currents) and then deactivated by 6 sec step commands to various negative potentials. As shown in Figure 6 , there was a close correspondence between the two. There were three main differences. First, deactivation of I merg1a was preceded by a larger transient reactivation: this presumably reflected the greater steady-state inactivation of I merg1a at 0 mV than that of slow I K(M,ng) at Ϫ20 mV. Second, the threshold for activation of I merg1a was ϳ10 mV more positive than that for slow I K(M,ng) (Fig. 6 Ab,Bb): the reason for this is not known but may simply relate to different cell types. Third, whereas both showed a biexponential deactivation, the time constants for the two components of I merg1a deactivation measured at Ϫ50 mV were ϳ40% of those for deactivation of the slow I K(M,ng) measured at the same potential (Table 1 ). The time constants showed a comparable voltage dependence (Fig. 6,compare Ac, Bc), so this ; n ϭ 4; filled circles, I merg1a ; n ϭ 6). See Table 2 for fitted parameters. difference may be explained by the different activation thresholds and/or the different size of the voltage step (in four CHO cells using a prepulse protocol, the first and the second slow deactivation values for I merg1a were slower after a prepulse to Ϫ20 mV compared with a prepulse to 0 mV, by 41 and 57%, respectively).
For comparison, we also examined the properties of currents generated by the short "cardiac" isoform merg1b expressed in CHO cells (I merg1b ; n ϭ 3; data not shown). Whereas the voltage dependence of I merg1b activation and deactivation were very similar to that of the slow I K(M,ng) and of I merg1a , both activation and deactivation of I merg1b were several times faster (Table 1) , as previously reported in oocytes by L ondon et al. (1997) (see also Lees-Miller et al., 1997) . Hence, and in accordance with the lack of antibody staining mentioned above and the absence of merg1b mRNA expression in the nervous system (L ondon et al., 1997), it is unlikely that merg1b channels contribute to slow I K(M,ng) .
Slow I K(M,ng) and I merg1a show similar pharmacology
We next compared the sensitivity of the slowly deactivating component of the NG108 -15 current I K(M,ng) with that of CHOexpressed merg1a currents to some blocking drugs. As shown in Figure 7 , both tail currents were blocked by the anti-arrhythmic drug WAY 123,398 with equal facility (IC 50 values, 0.4 and 0.3 M, respectively; Table 2 ). They were also equally sensitive to another anti-arrhythmic drug, azimilide (IC 50 values, 6.4 and 6.5 M, respectively; Table 2 ; Busch et al., 1998) . I merg1a was also inhibited by 9-aminotetrahydroacridine (THA; IC 50 value, 36 M; Table 2), a compound that had previously proved unexpectedly potent in inhibiting the M-like current in NG108 -15 cells (Robbins et al., 1992) . In contrast, neither current was inhibited by the ganglionic M channel-and KCNQ2/3 channel-blocking agent linopirdine at concentrations up to 30 M [Noda et al. (1998) reported an IC 50 of 36 M against the NG108 -15 current, but this was measured from the depression of the composite current, and the Hill slope was rather shallow, so probably reflected its primary action on the fast current component, see below]. Also, both currents were very insensitive to tetraethylammonium (TEA), with IC 50 values of 17 and 24 mM (Table 2) . Thus, I merg1a provides a good match for the slowly deactivating component of I K(M,ng) , both kinetically and pharmacologically.
Fast I K(M,ng) is mimicked by the M current (I K(M) ) in mouse sympathetic neurons
As noted above (Fig. 1) , the fast component of I K(M,ng) was readily suppressed by 10 M linopirdine. Since linopirdine blocks M currents in sympathetic ganglia (Lamas et al., 1997; Wang et al., 1998) , this suggested that fast I K(M,ng) might correspond to the "true" (ganglionic-type) M current. We assessed this by comparing fast WAY-insensitive I K(M,ng) with the M current recorded from dissociated mouse SCG neurons. (We used mouse neurons because (1) the parent neuroblastoma to the NG108 -15 hybrid cell line is derived from mouse neural crest; and (2) sequence analysis of the PCR products obtained with the KCNQ primers showed that NG108 -15 cells expressed both the mouse KCNQ2 and the mouse KCNQ3. Because we have successfully used these primers to amplify the rat KCNQ2 and KCNQ3 genes, we conclude that NG108 -15 cells express predominantly, if not exclusively, the mouse KCNQ genes.) Figure 8 shows families of fast I K(M,ng) (Aa) and I K(M) (Ba) activated by membrane depolariza- 
tion to Ϫ20 mV and deactivated by 1 sec hyperpolarizations at Ϫ30 to Ϫ100 mV. The slow component of I K(M,ng) was eliminated using 10 M WAY 123,398, as shown in the box in Figure 8 . Fast I K(M,ng) and I K(M) had similar voltage dependences (Fig. 8 A,B) to each other, and also to slow I K(M,ng) and I merg1a (compare Fig. 6 ). However, unlike slow I K(M,ng) , deactivation tails of fast I K(M,ng) and mouse I K(M) were fitted with single exponential curves: these had time constants similar to each other but much shorter than those in the slow I K(M,ng) and I merg1a (Table 1) .
Pharmacological comparison of fast I K(M,ng) and mouse I K(M)
Like fast I K(M,ng) , mouse I K(M) was unaffected by 10 M WAY 123,398. I K(M) recorded from 5 rat SCG neurons was also insensitive to this compound. Furthermore, both fast I K(M,ng) and mouse I K(M) were 1.5-2 orders of magnitude less sensitive to THA than were slow I K(M,ng) or I merg1a (IC 50 values, 1.5 and 1.3 mM; Table 2 ). This accords with the relative insensitivity of rat SCG I K(M) to THA reported previously . Figure 9 shows the responses of fast I K(M,ng) and mouse I K(M) to linopirdine and TEA. Whereas both currents were considerably more sensitive than slow I K(M,ng) or I merg1a to linopirdine, the neuroblastoma-glioma current was clearly more sensitive than the mouse SCG current (IC 50 values, 1.2 and 3.5 M, respectively; Table 2 ). Likewise, fast I K(M,ng) was more readily blocked than the mouse I K(M) by TEA (see Discussion). Nevertheless, although not completely identical pharmacologically, fast I K(M,ng) and Both fast and slow I K(M,ng) , and I merg1a , are inhibited through activation of M1 muscarinic receptors Activation of M 1 muscarinic receptors inhibits both the total (composite) M-like current (I K(M,ng) ) in NG108 -15 cells (Fukuda et al., 1988; Robbins et al., 1991 Robbins et al., , 1993 , and the M current I K(M) in rat (Marrion et al., 1989; Bernheim et al., 1992) and mouse (Hamilton et al., 1997) sympathetic neurons. We therefore examined the effects of a muscarinic stimulant, oxotremorine-M (Oxo-M; 10 M), on each component of I K(M,ng) , as well as I merg1a , in M 1 muscarinic receptor-transformed NG108 -15 and CHO cells. Figure 10 shows that Oxo-M inhibited the slow I K(M,ng) ( A) and I merg1a ( B) . Such inhibitions were observed in seven of eight NG108 -15 cells (mean inhibition, 42.3 Ϯ 13.8%) and six of six merg1a-expressing CHO cells (mean inhibition, 50.7 Ϯ 10.8%). Inhibition of both slow I K(M,ng) and I merg1a was accompanied by a significant acceleration of their deactivation kinetics (Fig. 11) : on average, the two components in slow I K(M,ng) and I merg1a were shortened by 25.4 Ϯ 10.0% and 34.6 Ϯ 9.0% (n ϭ 6) and 36.5 Ϯ 4.8% and 27.8 Ϯ 10.1% (n ϭ 4), respectively. Figure 12 shows examples of inhibitions of fast I K(M,ng) and mouse I K(M) by Oxo-M. Such inhibitions were observed in four of four NG108 -15 cells (mean inhibition, 72.6 Ϯ 13.8%; n ϭ 4). As expected (Hamilton et al., 1997) , similar inhibition was consistently observed in sympathetic neurons.
Fast and slow I K(M,ng) control firing in NG108-15 cells
The function of the M current is to act as a brake on repetitive firing. Thus, inhibition of the M current in sympathetic neurons, either by muscarinic agonists (Brown and Selyanko, 1985) or by an M channel-blocking agent (Wang et al., 1998) , is associated with increased repetitive firing during depolarizing current injections. A similar effect has also been reported in M 1 -transformed NG108 -15 cells after application of a muscarinic agonist (Robbins et al., 1993) . However, in the latter case, it is not clear whether this results from inhibition of the fast or slow I K(M,ng) , or both. We tested this by injecting long (7 sec) depolarizing currents into NG108 -15 cells and then observing the effects of Table 2. selectively inhibiting fast and slow I K(M,ng) with linopirdine and WAY 123,398, respectively. The depolarizing currents produced a short burst of repetitive firing in 20 of 22 NG108 -15 cells tested and single action potentials in the remaining two cells. Figure 13 shows that 30 M linopirdine (which blocked the fast current completely and inhibited the slow I K(M,ng) by only 33%) produced a strong reduction in spike adaptation, whereas 10 M WAY 123,398 had a much weaker effect. Neither linopirdine nor WAY 123,398 had any effect on spike repolarization.
DISCUSSION
The main point emerging from this work is that the M-like current in NG108 -15 cells (I K(M,ng) ) is a composite current generated by at least two channel types: a fast-deactivating set of channels similar (but not quite identical) to those carrying the M current in mouse sympathetic neurons and tentatively identified as KCNQ2/KCNQ3 (Wang et al., 1998) , and a slower-deactivating current probably formed from merg1a (L ondon et al., 1997).
KCNQ2 and KCNQ3 are analogs of KCNQ1, which coassembles with KCNE (minK) subunits to give the cardiac current I K s (the slow component of the cardiac "delayed rectifier"), and mutation of which causes one form of the cardiac long QT syndrome (Yang et al., 1997) . KCNQ2 and KCNQ3 have so far been detected only in brain and ganglia, and are implicated in a form of juvenile epilepsy (Biervert et al., 1998; Charlier et al., 1998; Singh et al., 1998; Yang et al., 1998) . Merg1a is one isoform of the mouse homolog of erg, originally cloned from a rat brain hippocampal cDNA library (Warmke and Ganetzky, 1994) ; mRNA for erg is found mainly in heart and brain (London et al., 1997; Wymore et al., 1997) . Mutations of the human homolog HERG give rise to a cardiac long QT syndrome (Curran et al., 1995; Sanguinetti et al., 1996) , whereas mutations in Drosophila erg are responsible for the seizure phenotype associated with hyperactivity in the flight motor pathway (Titus et al., 1997; Wang et al., 1997) . Thus, both these channel types have been implicated in the control of excitability in vivo. This is the first example of these two channels forming overlapping and f unctionally similar components of membrane current.
Our conclusion that two different channels are involved is based on: (1) the presence of mRNA transcripts and protein; (2) biophysical properties (voltage threshold and deactivation parameters); (3) sensitivity to potassium channel blockers; and (4) modulation of the channel by an agonist. Thus, we demonstrate the presence of mRNA and protein for merg1, and mRNA for KCNQ2 and KCNQ3, in NG108 -15 cells. We show that the kinetics of merg1a heterologously expressed in mammalian cells correspond closely to those of the slow I K(M,ng) . We also show that the two are equally sensitive to the merg-selective blocking agents WAY 123,398 and azimilide, and insensitive to the ganglionic M current and KCNQ2/3 channel-blocking agent linopirdine. On the other hand, we find that the fast I K(M,ng) kinetically matches the mouse SCG I K(M) , that these two are pharmacologically similar (although not quite identical), and that they can be distinguished from both slow I K(M,ng) and I merg1a by their greater sensitivity to linopirdine and insensitivity to WAY 123,398. We also show that both fast and slow components of I K(M,ng) are inhibited by stimulating M 1 muscarinic acetylcholine receptors and that the nature of the inhibition of these two components matches that for inhibition of mouse I K(M) and I merg1a , respectively.
I K(M) in rat ganglion cells has been ascribed to current through channels composed of heteromultimeric assemblies of expressed KCNQ2 and KCNQ3 subunits (Wang et al., 1998) . This may also be true for I K(M) in mouse ganglion cells and for the fast component of I K(M,ng) in NG108 -15 cells, because we have found that both cell types show transcripts for these subunits. However, as yet, we cannot exclude a contribution from other, homologous, KCNQ subunits. Furthermore, fast I K(M,ng) was distinctly more sensitive to TEA and to linopirdine than was mouse ganglion I K(M) , suggesting that the subunit composition of the presumed-KCNQ channels in these two cell types might differ.
The presence of functional merg1a channels in these cells is not, in itself, particularly surprising, because mRNA transcripts have been identified in a number of neuroblastoma-derived cells (including NG108 -15) using probes to the human homolog HERG (Bianchi et al., 1998) , and an "inwardly rectif ying" current, retrospectively similar to an erg current, was reported in NG108 -15 cells by Hu and Shi (1997) (see also Bianchi et al., 1998) . However, in previous experiments, the properties of this current were mostly studied using solutions containing a raised K ϩ concentration, so that its relation to the M-like current was difficult to discern. It is clear from the present experiments (using normal external K ϩ concentrations) that the activation range of I merg1a overlaps that of the true I K(M) , but that deactivation of I merg1a contributes a distinctive slow component to composite current deactivation; and f urthermore, that the proportional contributions of I merg1a and I K(M) to the total M-like current vary appreciably from cell to cell.
The merg1a and (presumed) KCNQ currents also overlap functionally. Thus, Chiesa et al. (1997) have provided evidence that erg channels play a role in spike frequency adaptation in another neuroblastoma-derived cell line, not dissimilar to the role of ganglionic M channels (Jones and Adams, 1987; Brown, 1988) . In the present experiments, it appeared that inhibition of the fast (M) channels had more effect on the response of NG108 -15 cells to a sustained current injection than did inhibition of the slow (merg) channels (Fig. 13) . However, the relative contribution of these two currents to spike frequency adaptation may depend on the nature of the testing pulse protocol, because merg currents activate and deactivate more slowly than KCNQ currents, and hence accumulate during repetitive depolarization (Schonherr et al., 1999) .
The transduction mechanism for M 1 -mediated inhibition of KCNQ2/3 and merg1 is still unknown. Inhibition of I merg1a and slow I K(M,ng) was accompanied by accelerated deactivation, which may indicate the involvement of protein kinase C (PKC); in HERG currents expressed in Xenopus oocytes, similar acceleration produced by thyrotropin-releasing hormone receptor activa- tion was mediated by PKC (Barros et al., 1998) . This would accord with an earlier proposal regarding the mechanism of inhibition of the M-like current in NG108 -15 cells by bradykinin (Higashida and Brown, 1986) . Although M 1 receptor activation in NG108 -15 cells produces a strong elevation in intracellular [Ca 2ϩ ] (Robbins et al., 1993) , it is unlikely that C a 2ϩ could be a messenger for muscarinic inhibition of slow I K(M,ng) or I merg1a because, in CHO cells, the C a 2ϩ ionophore ionomycin (5 M) produced an insignificant reduction in I merg1a (to 89.4 Ϯ 9.7% of control; n ϭ 3). As a control for the effectiveness of ionomycin in these cells, it caused a complete block of Kv1.2 channels expressed in CHO cells when recorded in perforated-patch or cell-attached configurations; direct application of 500 nM Ca 2ϩ blocked Kv1.2 channels when recorded in the inside-out configuration (A. A. Selyanko and J. K . Hadley, unpublished observations).
Do products of erg genes contribute to M-like currents in other neurons? Transcripts for merg1 (L ondon et al., 1997) , and for the rat homologs erg1 and erg3 Wymore et al., 1997) are present in mammalian brain. Furthermore, both expressed merg1a currents and the slow, presumed-merg1a component of the M-like current in NG108 -15 cells were inhibited by stimulating M 1 muscarinic receptors, so they could contribute to muscarinic-inhibitable M-like currents previously recorded in central neurons. True, the presence of mRNA transcripts may not betoken the assembly of f unctional channels: thus, no appropriate erg-like component of membrane current could be recorded from mouse or rat sympathetic neurons, in spite of the presence of mRNAs ; see also this paper), nor could we detect merg1 immunoreactivity. However, this may not be the case for other mammalian neurons. For example, the M-like current recorded from isolated rat cortical neurons has been reported to be an order of magnitude less sensitive to linopirdine than either the ganglionic or hippocampal cell current (Noda et al., 1998; cf. Aiken et al., 1995; Lamas et al., 1997; Schnee and Brown, 1998 ). Although other explanations are possible, our findings suggest that this might arise from a contribution by erg channels to the cortical neuron current. In view of the significance of M-like channels as potential targets for cognition-enhancing drugs (Zaczek and Saydoff, 1993) , f urther information regarding the degree of heterogeneity in the molecular composition of the channels underlying M-like currents in different neurons would be helpful.
